Hostname: page-component-586b7cd67f-l7hp2 Total loading time: 0 Render date: 2024-12-01T03:44:18.452Z Has data issue: false hasContentIssue false

SHEA Conference on Antimicrobial Resistance

Published online by Cambridge University Press:  02 January 2015

Dale N. Gerding*
Affiliation:
Medical Service, Lakeside Division, VA Chicago Health Care System, Department of Medicine, Northwestern University Medical School, Chicago, Illinois
William J. Martone
Affiliation:
National Foundation for Infectious Diseases, Bethesda, Maryland
*
icon, inc, 12982 Valley View Rd, Eden Prairie, MN 55344

Abstract

Antimicrobial resistance is an increasing problem in healthcare institutions and in the community. Public concern about resistance is also increasing. The issue is broad and complex and not readily addressed by government, industry, or professional societies alone. On October 29-30,1998,19 representatives of various professional societies and governmental agencies met under the auspices of the Society for Healthcare Epidemiology of America (SHEA) at Brook Lodge Conference Center in Augusta, Michigan. The purpose of the meeting was to discuss the current status of antimicrobial resistance in the United States and Canada, including present society and governmental efforts to address the problem. Representatives exchanged experiences through presentations and discussions on the first day, then on the second day held a brainstorming session to address future needs and priorities in addressing the resistance problem. It was agreed that a national coordinated effort was needed. As part of this national effort, representatives called for the creation of a National Coalition on Antibiotic Resistance (NCAR) to combat antibiotic resistance through education, research, prevention, and advocacy. Priorities for NCAR were focused in four areas: (1) education of the public and professionals; (2) support of basic and applied research; (3) provision of an information resource and clearinghouse; and (4) advocacy initiatives. At the recommendation of the SHEA Board, discussions with the National Foundation for Infectious Diseases for the joint development of NCAR have begun.

Type
Special Report
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2000

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Shlaes, DM, Gerding, DN, John, JF Jr, Craig, WA, Bornstein, DL, Duncan, RA, et al. Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: guidelines for the prevention of antimicrobial resistance in hospitals. Infect Control Hosp Epidemiol 1997;18:275291.Google Scholar
2. Controlling antimicrobial resistance: an integrated action plan for Canadians. Can Commun Dis Rep 1997;23(suppl 7): 132.Google Scholar
3. Dowell, SF. Principles of judicious use of antimicrobial agents for pediatric respiratory tract infections. Pediatrics 1998;101(part 2):163184.Google Scholar
4. Principles of Judicious Use of Antimicrobial Agents: A Compendium for Health Care Professionals. Elk Grove Village, IL: American Academy of Pediatrics; 1998.Google Scholar
5. Report of the ASM task force on antibiotic resistance. Antimicrob Agents Chemother 1995;Google Scholar
6. Goldmann, DA, Weinstein RA Wenzel, RP, Tablan, OC, Duma, RJ, Gaynes, RP, et al. Strategies to prevent and control the emergence and spread of antimicrobial-resistant microorganisms in hospitals: a challenge to hospital leadership. JAMA 1996;275:234240.CrossRefGoogle ScholarPubMed